STAFF PROFILE
Distinguished Professor Charlie Xue
Professor Charlie C. Xue is Executive Dean, School of Health and Biomedical Sciences at RMIT University. He provides academic, research, professional, industry and community engagement leadership.
Professor Charlie Xue commenced his current role as Executive Dean SHBS in January 2016. He has consulted staff extensively for the development of the Guiding Principles for School Operations (2016-2020), School Academic Structure (11 Disciplines under three Academic Clusters), identification of the School’s Teaching, Research and Business Development Priorities, finalisation of the School’s Mission and Vision, and development of the School’s Workplan (to 2020) with an annual School Operational Plan.
The School will achieve its objectives through teamwork and collaboration, delivery of quality student experience and research output and recognition of staff strengths and success. Previously at RMIT University, Prof Xue was Head of School, Health Sciences (2011-2015) and Foundation Discipline Leader Chinese Medicine (1996-2010).
Outside the School, Professor Xue contributes to the strategic direction setting of the College of Science Engineering and Health as a member of the College Executive. Professor Xue works collaboratively with other members of the College Executive for the planning and development of academic programs, cross-disciplinary research and business development/commercial activities. He also contributes to the RMIT University’s Academic Board, Academic Promotion Review Panels and the Athena SWAN Committee to address the gender balance in the academic workforce.
Professor Xue also holds the following appointments:
- Senior Principal Research Fellow, Guangdong Provincial Academy of Chinese Medical Sciences, China [from 2011-]
- National Chair, Chinese Medicine Board of Australia, an appointment by the Australian Health Workforce Ministerial Council [from 2011-]
- Member, World Health Organization (WHO) Expert Advisory Panel for Traditional Medicine (appointed by Director-General of the WHO, Geneva [from 2007-]
- Chair, Terminology Committee, International Classification of Traditional Medicine; and Member, Project Advisory Group, WHO, Geneva [from 2008-]
- Director, WHO Collaborating Centre for Traditional Medicine, RMIT University [from 2005-]
- Director, Chinese Medicine Confucius Institute, RMIT University [from 2008-]
Research interests
Professor Xue's main research interests are evidence-based medicine and translational research with a focus on Complementary and Alternative Medicine (CAM, acupuncture and herbal medicine) for chronic respiratory diseases and pain management. His team consists of six postdoctoral fellows and fifteen PhD candidates. He has established extensive research networks nationally and internationally. Professor Xue’s research has been supported by over AU$23 million of research grants including six Australian National Health and Medical Research Council (NHMRC) Project Grants, two Australian Research Council (ARC) Linkage Grants, and more than 30 Federal and State Government Grants, as well as a number of major international research collaboration grants.
Selected recent research grants
- Randomised sham-controlled trial of acupuncture for postmenopausal hot flushes (NHMRC, 2011-2014, $482,971) [CIC]
- The effect of a standardised ginseng extract in patients with moderate COPD: a randomised, double blind trial (NHMRC, 2010-2016, $560,375) [CIA]
- The efficacy and safety of acupuncture for seasonal allergic rhinitis: a prospective, randomised controlled trial (NHMRC, 2009-2014, $169,725) [CIA]
- Electro-acupuncture on opioid consumption by patients with chronic musculoskeletal pain: a randomised controlled trial (NHMRC, 2009-2014, $353,650) [CIA]
- Combined electro-acupuncture and cognitive behavioural therapy for tension-type headache: a randomised controlled trial (NHMRC, 2009-2013, $292,025) [CIB]
- Randomised controlled trials of acupuncture vs. pharmacotherapy for acute pain relief in emergency departments (NHMRC, 2009-2012, $400,023) [CID]
- Cultural Aspects in the Development of Evidence-Based Chinese Medicine - Stages 1-5. Funded by: Confucius Institute Headquarters Business Development Program Fund from (2011 to 2015) - $700,000 [CIA]
Honours and awards
- Office of Learning and Teaching Citation (Team Leader), Australian Government, 2013
- RMIT Learning and Teaching Award (Team Leader), RMIT University, 2012
- Vice Chancellor Research Excellence Award, RMIT University, 2011
- Honorary Member, The Golden Key International Honour Society, 2011
- Ralph McIntosh Medal, Council of RMIT University, May 2010
- Wang Ding Yi International Contribution to Chinese Medicine Award (Team Leader), World Federation of Chinese Medicine Societies, 2008
- RMIT University Research Awards, 2004 and 2005
Research grant reviews and contribution to peer reviewed journals
Professor Xue contributes to peer-review process for major grant funding schemes (including the NHMRC GRP 2011-2013), journals as Advisory/Editorial Board Members (including Cochrane Collaboration’s CAM Field, JACM), and as a reviewer (including Allergy, American Journal of Epidemiology, JAMA, PLoSOne, WHO Bulletin).
Industry and international consultancy
- Consultant/Chair/Advisor: for over 20 projects for the WHO [from 2002-]
- Member, Expert Advisory Panel for Chinese Medicine Regulation, Ministry of Health, New Zealand, from 2010
- Member, International Chinese Medicine Advisory Committee, The State Administration of Traditional Chinese Medicine, Chinese Government, Beijing, P.R. China, from Jan 2000
- Honorary Advisor, Institute of Chinese Medicine, The Chinese University of Hong Kong, from August 2001
- Doctor of Philosophy, RMIT University, 2000, Australia
- Bachelor of Medicine, Guangzhou College of Chinese Medicine, 1987, China
- Coyle, M.,Liang, H.,Wang, K.,Zhang, A.,Xue, C.,Li, H. (2019). Evidence-based Clinical Chinese Medicine Volume 6: Herpes Zoster and Post-herpetic Neuralgia, World Scientific Publishing Co., Singapore
- Zheng, Z.,Gibson, S.,Helme, R.,Wang, Y.,Lu, D.,Arnold, C.,Hogg, M.,Somogyi, A.,Da Costa, C.,Xue, C. (2019). Effects of electroacupuncture on opioid consumption in patients with chronic musculoskeletal pain: A multicenter randomized controlled trial In: Pain Medicine, , 1 - 14
- Coyle, M.,Liang, H.,Parker, S.,Zhang, T.,Xue, C.,Li, H. (2019). Evidence-Based Clinical Chinese Medicine - Volume 11: Acne Vulgaris, World Scientific Publishing Company, Singapore
- Yu, X.,Mao, Y.,Shergis, J.,Coyle, M.,Wu, L.,Chen, Y.,Zhang, T.,Lin, L.,Xue, C.,Xu, Y. (2019). Effectiveness and Safety of Oral Cordyceps sinensis on Stable COPD of GOLD Stages 2-3: Systematic Review and Meta-Analysis In: Evidence-Based Complementary and Alternative Medicine, 2019, 1 - 12
- Zhang, L.,Yang, L.,Shergis, J.,Zhang, L.,Zhang, T.,Guo, X.,Qin, X.,Johnson, D.,Liu, X.,Lu, C.,Xue, C.,Mao, W. (2019). Chinese herbal medicine for diabetic kidney disease: A systematic review and meta-analysis of randomised placebo-controlled trials In: BMJ Open, 9, 1 - 13
- Ni, X.,Shergis, J.,Zhang, T.,Guo, X.,Lu, C.,Li, Y.,Xue, C. (2019). Traditional Use of Chinese Herbal Medicine for Insomnia and Priorities Setting of Future Clinical Research In: Journal of Alternative and Complementary Medicine, 25, 8 - 15
- Zhang, S.,Zhang, C.,Tan, H.,Wang, Y.,Da Costa, C.,Zhang, T.,Xue, C.,Xie, M. (2018). Systematic review of acupuncture placebo devices with a focus on the credibility of blinding of healthy participants and/or acupuncturists In: Acupuncture in Medicine, 36, 204 - 214
- Yang, L.,Di, Y.,Shergis, J.,Li, Y.,Zhang, T.,Lu, C.,Guo, X.,Xue, C. (2018). A systematic review of acupuncture and Chinese herbal medicine for postpartum depression In: Complementary Therapies in Clinical Practice, 33, 85 - 92
- Wong Lit Wan, D.,Arendt-Nielsen, L.,Wang, K.,Xue, C.,Wang, Y.,Zheng, Z. (2018). Pain Adaptability in Individuals With Chronic Musculoskeletal Pain Is Not Associated With Conditioned Pain Modulation In: Journal of Pain, 19, 897 - 909
- Zhang, S.,Luo, Q.,Coyle, M.,Di, Y.,Zhang, A.,Xue, C.,Yang, L.,Li, Y.,Xia, J. (2018). Evidence-based Clinical Chinese Medicine Volume 5: Allergic Rhinitis, World Scientific Publishing Co., Singapore
- Cultural Aspects in the Development of Evidence-Based Chinese Medicine - Stages 6. Funded by: Confucius Institute Headquarters Business Development Program Fund from (2016 -2017) - $220,000 [CIA]
- Evaluation of Traditional and Scientific Evidence of Chinese Medicine (Stage I, II and III projects), Guangdong Provincial Academy of Chinese Medical Sciences, 2008-2016, $3,050,000): [CIA]
- The China-Australia Research Centre for Chinese Medicine, 2013-2020, $2,400,000: CIA and Co-Director of the Centre
- Translational Medicine Projects at the China-Australia Research Centre for Chinese Medicine, 2016-2025, $8,229,113, CIA and Director of the Centre
33 PhD Completions and 9 Masters by Research Completions9 PhD Current Supervisions